See Mereo BioPharma Group PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

54.29M

Dividend TTM

0.00

P/E TTM

-1.54

EPS TTM

-0.22

Revenue

500.00K

Net Profit

-29.47M

ROE

-75.87%

ROA

-65.56%

Mereo BioPharma Group PLC Earnings Date

Latest Release

Aug 11, 2026

EPS / Forecast

-0.04/-0.01

Revenue / Forecast

0.00/2.33M

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2023H1

FY2022Q4

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

Financial Indicators

EPS

52.30%-0.04

49.00%-0.04

---0.05

54.93%-0.04

-6.16%-0.09

-28.56%-0.08

----

---0.10

---0.09

---0.06

----

Revenue

-100.00%0.00

----

--0.00

--500.00K

----

--0.00

----

--8.79M

----

--0.00

-100.00%0.00

--0.00

--50.59M

----

Net Profit

52.07%-7.00M

47.86%-6.72M

-4.33%-7.35M

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

----

45.31%-13.60M

----

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

Net Margin

----

---2923.20%

----

Gross Margin

----

--73.60%

----

Debt to assets ratio

----

-100.00%0.00%

9.66%7.25%

--6.25%

--5.13%

--8.28%

--6.61%

----

Income Statement

Revenue

-100.00%0.00

----

--0.00

--500.00K

----

--0.00

----

--8.79M

----

--0.00

-100.00%0.00

--0.00

--50.59M

----

Operating profit

33.04%-7.03M

21.75%-8.77M

45.07%-8.39M

-6.85%-10.02M

18.07%-10.50M

-13.15%-11.20M

---15.28M

---9.37M

---12.81M

---9.90M

----

44.37%-15.74M

----

9.56%-25.55M

-9899.49%-28.30M

-3.64%-28.25M

98.65%-283.02K

-2.41%-27.26M

13.67%-21.03M

-24.58%-26.62M

1.37%-24.36M

14.02%-21.37M

Net Profit

52.07%-7.00M

47.86%-6.72M

-4.33%-7.35M

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

----

45.31%-13.60M

----

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

Balance Sheet

Current assets

-45.62%33.40M

-40.16%40.03M

-39.78%45.02M

-39.57%52.41M

-34.62%61.42M

25.05%66.90M

17.26%74.76M

--86.72M

--93.94M

--53.50M

--63.76M

----

-30.83%68.89M

----

-44.07%75.16M

-40.14%99.60M

230.61%134.37M

101.25%166.39M

0.72%40.64M

33.25%82.68M

-8.30%40.35M

-4.59%62.05M

----

Total current liabilities

-24.88%5.68M

-17.61%6.18M

-68.93%4.30M

-57.66%6.02M

-51.14%7.56M

-31.87%7.50M

45.98%13.85M

--14.21M

--15.47M

--11.00M

--9.49M

----

-48.26%22.18M

----

75.94%29.85M

214.02%42.86M

44.88%16.97M

-50.78%13.65M

-70.44%11.71M

3.73%27.73M

91.96%39.62M

43.13%26.74M

----

Total assets

-44.57%34.71M

-40.56%40.61M

-39.89%45.92M

-39.60%53.60M

-34.85%62.63M

22.14%68.32M

14.87%76.39M

--88.75M

--96.13M

--55.94M

--66.50M

----

-22.12%102.44M

----

-37.70%106.55M

-34.36%131.53M

98.72%171.03M

47.21%200.38M

-24.91%86.07M

0.09%136.12M

33.56%114.62M

25.45%135.99M

----

Total liabilities

-28.29%6.06M

-20.40%6.56M

-67.57%5.00M

-56.79%7.00M

-51.63%8.45M

-37.09%8.24M

-3.39%15.42M

--16.21M

--17.48M

--13.10M

--15.96M

----

-37.87%29.08M

----

-38.99%31.71M

-47.29%46.81M

-51.22%51.97M

-16.26%88.82M

73.94%106.54M

73.68%106.06M

39.14%61.25M

32.36%61.07M

----

Total equity

-47.11%28.65M

-43.32%34.05M

-32.89%40.92M

-35.76%46.60M

-31.12%54.18M

40.25%60.08M

20.64%60.97M

--72.54M

--78.65M

--42.84M

--50.54M

----

-13.41%73.36M

----

-37.14%74.84M

-24.06%84.72M

681.63%119.06M

271.15%111.56M

-138.35%-20.47M

-59.88%30.06M

27.68%53.38M

20.33%74.93M

----

Cash Flow Statement

Net operating income

21.02%-6.04M

48.23%-4.31M

18.45%-7.68M

2.79%-7.31M

3.20%-7.65M

-4.23%-8.33M

---9.42M

---7.52M

---7.90M

---7.99M

----

30.85%-16.72M

----

-10.93%-22.89M

-275.98%-24.18M

18.95%-20.63M

193.21%13.74M

-7.31%-25.46M

59.94%-14.74M

-110.93%-23.72M

-69.36%-36.79M

57.67%-11.25M

Net investment

--0.00

6.25%-300.00K

--0.00

--300.00K

-100.00%0.00

54.29%-320.00K

--0.00

--1.00K

---700.00K

----

-139.96%-415.38K

----

100.00%0.00

--1.04M

-101.11%-575.08K

-100.00%0.00

-102.54%-285.95K

-95.21%2.10M

60024.22%11.27M

169764.16%43.92M

99.70%-18.81K

Net financing

100.00%0.00

-100.00%0.00

197.50%39.00K

100.00%0.00

-100.29%-134.00K

--422.00K

---40.00K

---594.00K

--46.78M

--0.00

----

52.83%-178.72K

----

-19.09%-577.76K

-100.35%-378.89K

97.03%-485.14K

71.35%108.22M

-802.09%-16.32M

2026.99%63.16M

-144.62%-1.81M

-1770.73%-3.28M

-102.31%-739.46K

FAQs

What is the total revenue of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its total revenue reached 500.00K, with a year-on-year change of 500.00K.

What are the current assets of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its current assets were 45.02M, with a year-on-year change of -39.78.

What are the total assets of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its total assets of Mereo BioPharma Group PLC were 45.92M, with a year-on-year change of -39.89.

What are the total liabilities of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its total liabilities of Mereo BioPharma Group PLC were 5.00M, with a year-on-year change of -67.57.

What is the total equity of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its total equity of Mereo BioPharma Group PLC was 40.92M, with a year-on-year change of -32.89.

What is the net operating income of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its net operating income of Mereo BioPharma Group PLC was -40.11M, with a year-on-year change of 15.32.

What is the net investment of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its net investment of Mereo BioPharma Group PLC was -20.00K, with a year-on-year change of 97.14.

What is the net financing of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its net financing of Mereo BioPharma Group PLC was 327.00K, with a year-on-year change of -99.29.

What is the Earnings Per Share (EPS) of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -0.26, with a year-on-year change of 12.43.

What is the operating profit of Mereo BioPharma Group PLC?



According to Mereo BioPharma Group PLC's FY2025 earnings report, its operating profit was -40.11M, with a year-on-year change of 15.32.